annual D&A:
$1.38M+$1.01M(+273.94%)Summary
- As of today (June 17, 2025), MLTX annual depreciation & amortization is $1.38 million, with the most recent change of +$1.01 million (+273.94%) on December 31, 2024.
- MLTX annual D&A is now at all-time high.
Performance
MLTX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$378.00K-$923.30K(-70.95%)Summary
- As of today (June 17, 2025), MLTX quarterly depreciation & amortization is $378.00 thousand, with the most recent change of -$923.30 thousand (-70.95%) on March 31, 2025.
- Over the past year, MLTX quarterly D&A has increased by +$50.00 thousand (+15.24%).
- MLTX quarterly D&A is now -70.95% below its all-time high of $1.30 million, reached on December 31, 2024.
Performance
MLTX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$1.43M+$50.00K(+3.61%)Summary
- As of today (June 17, 2025), MLTX TTM depreciation & amortization is $1.43 million, with the most recent change of +$50.00 thousand (+3.61%) on March 31, 2025.
- Over the past year, MLTX TTM D&A has increased by +$739.70 thousand (+106.43%).
- MLTX TTM D&A is now at all-time high.
Performance
MLTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
MLTX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +273.9% | +15.2% | +106.4% |
| 3 y3 years | - | +10000.0% | +10000.0% |
| 5 y5 years | - | - | - |
MLTX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +740.2% | -71.0% | +236.4% | at high | >+9999.0% |
| 5 y | 5-year | at high | +740.2% | -71.0% | +236.4% | at high | >+9999.0% |
| alltime | all time | at high | +740.2% | -71.0% | +236.4% | at high | >+9999.0% |
MLTX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $378.00K(-71.0%) | $1.43M(+3.6%) |
| Dec 2024 | $1.38M(+273.9%) | $1.30M(+3904.0%) | $1.38M(+212.0%) |
| Sep 2024 | - | $32.50K(-111.7%) | $443.80K(+7.0%) |
| Jun 2024 | - | -$277.10K(-184.5%) | $414.60K(-40.3%) |
| Mar 2024 | - | $328.00K(-9.0%) | $695.00K(+87.7%) |
| Dec 2023 | $370.30K | $360.40K(>+9900.0%) | $370.30K(+123.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $3300.00(0.0%) | $165.60K(0.0%) |
| Jun 2023 | - | $3300.00(0.0%) | $165.60K(0.0%) |
| Mar 2023 | - | $3300.00(-97.9%) | $165.60K(+0.5%) |
| Dec 2022 | $164.80K | $155.70K(+4618.2%) | $164.80K(+1711.0%) |
| Sep 2022 | - | $3300.00(0.0%) | $9100.00(+56.9%) |
| Jun 2022 | - | $3300.00(+32.0%) | $5800.00(+132.0%) |
| Mar 2022 | - | $2500.00 | $2500.00 |
FAQ
- What is MoonLake Immunotherapeutics annual depreciation & amortization?
- What is the all time high annual D&A for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual D&A year-on-year change?
- What is MoonLake Immunotherapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly D&A year-on-year change?
- What is MoonLake Immunotherapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM D&A year-on-year change?
What is MoonLake Immunotherapeutics annual depreciation & amortization?
The current annual D&A of MLTX is $1.38M
What is the all time high annual D&A for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual depreciation & amortization is $1.38M
What is MoonLake Immunotherapeutics annual D&A year-on-year change?
Over the past year, MLTX annual depreciation & amortization has changed by +$1.01M (+273.94%)
What is MoonLake Immunotherapeutics quarterly depreciation & amortization?
The current quarterly D&A of MLTX is $378.00K
What is the all time high quarterly D&A for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly depreciation & amortization is $1.30M
What is MoonLake Immunotherapeutics quarterly D&A year-on-year change?
Over the past year, MLTX quarterly depreciation & amortization has changed by +$50.00K (+15.24%)
What is MoonLake Immunotherapeutics TTM depreciation & amortization?
The current TTM D&A of MLTX is $1.43M
What is the all time high TTM D&A for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM depreciation & amortization is $1.43M
What is MoonLake Immunotherapeutics TTM D&A year-on-year change?
Over the past year, MLTX TTM depreciation & amortization has changed by +$739.70K (+106.43%)